-
Nursing federation demands proper pay, protection on Ebola front line
-
In wildfire town, PM says UK must 'face up to climate change'
-
France upholds assisted dying law, strikes down social media ban for children
-
In town hit by wildfire, PM says UK must 'face up to climate change'
-
Body found after wildfire hits Croatian coastal town
-
UK parliament probe into Farage resumes after polls win
-
Arteta expects Maresca to do an 'unbelievable job' at Man City
-
Italian police recover stolen Renoir, Cezanne and Matisse worth 9 mn euros
-
Stocks tread water with eyes on oil price
-
Prize money 'critical' for athletics, says Coe
-
US retail sales weakest in over a year in July
-
WHO decries lack of justice over 10,000 attacks on health care
-
Israel calls for police to replace military in handling West Bank settlers
-
SNC SCANDIC PAY: Betala – över hela världen och utan gränser
-
स्कैंडिक पे: दुनिया में कहीं भी, बिना किसी सीमा के भुगतान करें।
-
SNC SCANDIC ÍOC: Íoc in áit ar bith ar domhan, gan teorainn
-
SNC SCANDIC PAY: Platby po celém světě bez omezení
-
SNC SCANDIC PAY: Płatności na całym świecie bez ograniczeń
-
SNCスカンディックペイ):世界中で、制限なくお支払いいただけます
-
SNC 스칸딕 페이: 전 세계 어디서나, 제한 없이 결제하세요
-
斯堪迪克支付:全球無界支付
-
SNC SCANDIC PAY: الدفع في جميع أنحاء العالم ودون حدود
-
СНК СКАНДІК ПЕЙ: Оплата по всьому світу без обмежень
-
СНК Скандик Пэй: Оплата по всему миру без границ
-
SNC SCANDIC PAY: Pay anywhere in the world, without limits
-
Europe wildfires: latest developments
-
Maresca uncertain over Rodri's future at Man City
-
Hotter Europe isn't cooling investor fervor for stocks
-
MEXC's August 2026 Proof of Reserves Confirms User Assets Fully Backed as Reserve Ratios Remain Above 100%
-
Duplantis into pole vault final at Euros
-
Zambia suspends vote counting nationwide citing violence
-
Maresca says 'anything can happen' amid talk of Rodri move to Barcelona
-
Coe pledges court showing to defend World Athletics over Russia stance
-
Indonesian leader vows to shut over 750 'unproductive' state-owned firms
-
Stocks mixed as oil climbs, dollar drops
-
NATO jets shoot down drone in Latvian airspace: spokesperson
-
Tourists beat the heat with 'magical' Colosseum night tours
-
Wildfire forces hundreds to flee in western Germany
-
Spain extends largest nuclear plant in policy U-turn
-
Croatian wildfire forces thousands to flee, injures dozens
-
Gill says 'huge honour' to lead India in 600th Test
-
Latest developments: Europe battles wildfires
-
Brazilian police recover Matisse works stolen in 2025
-
Is a new conflict brewing in northern Ethiopia?
-
Exiled Putin critic says push for peace put him in danger
-
UK firefighters 'under pressure' as multiple blazes rage
-
EU to study potential vaccine for Lyme disease: companies
-
ARKBRIDGE Reaches 50,000 Clients and Launches New Referral Rewards Program
-
Colombia vows to find all missing quake victims as rescue hopes fade
-
New wildfire forces evacuation of 500 people in France
Japan drugmaker reports two more deaths in supplement scare
A Japanese drugmaker whose dietary supplements are at the centre of a growing health scare reported on Thursday two more deaths potentially related to its tablets.
Last week, Kobayashi Pharmaceutical recalled three supplement brands -- "Beni Koji Choleste Help" and two others -- after customer complaints of kidney problems.
The over-the-counter products contain an ingredient called red yeast rice, or "beni koji", which is supposed to help lower cholesterol.
Thursday's announcement brings the total number of deaths under investigation by the company and health ministry to four, with more than 100 other people hospitalised.
"We were told yesterday by a bereaved family that a person who had been using Choleste Help had passed away due to kidney disease," the drugmaker said in a statement.
It added it had been told separately that another person who had used Choleste Help in recent years had died.
"We are in the process of confirming the facts and causal relationships in both of these cases," the statement said.
"However, we decided to make this report public from the viewpoint of prompt disclosure."
Medical studies describe red yeast rice as an alternative to statins for lowering high cholesterol, but also warn of a risk of organ damage depending on its chemical make-up.
Kobayashi Pharmaceutical sells a wide range of health products marketed through television adverts in Japan.
The Osaka-based company says it has also supplied red yeast rice to around 50 other firms in Japan and two in Taiwan.
Government spokesman Yoshimasa Hayashi said Thursday that authorities were doing "their utmost to ensure food safety, including identifying the substance that caused the health harm and how it became present in the product".
The government has ordered various health-food makers to review their products, while informing foreign countries about the issue through Japan's embassies, he said.
Dozens of Japanese firms that used beni koji provided by Kobayashi Pharmaceutical have also separately announced recalls.
The affected products include health tablets as well as a rose-coloured sparkling sake, salad dressing, bread and miso paste used in many traditional dishes.
Kobayashi Pharmaceutical has said analysis had found a possibility that the products contained "ingredients we had not intended to include".
But it said it did not find any citrinin produced by red yeast rice, which is toxic and can damage the kidneys.
M.AbuKhalil--SF-PST